Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$209.6K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Jun 30 | FDMT | 4D Molecular Therapeutics,… | SSELL◷ | 6,566 | $14.00 | $91.9K | -43.3% | Open the original filing on SEC.gov |
| Jun 30 | FDMT | 4D Molecular Therapeutics,… | MEXER◷ | 5,752 | $6.49 | $37.3K | +61.0% | Open the original filing on SEC.gov |
| Jun 30 | FDMT | 4D Molecular Therapeutics,… | MEXER◷ | 814 | $4.14 | $3.4K | +9.4% | Open the original filing on SEC.gov |
| Jun 23 | FDMT | 4D Molecular Therapeutics,… | MEXER◷◆ | 9,810 | — | — | — | Open the original filing on SEC.gov |
| Jun 23 | FDMT | 4D Molecular Therapeutics,… | SSELL◷ | 9,810 | $12.00 | $117.7K | -53.2% | Open the original filing on SEC.gov |
| Jun 23 | FDMT | 4D Molecular Therapeutics,… | MEXER◷ | 9,810 | $4.14 | $40.6K | +113.8% | Open the original filing on SEC.gov |
| Mar 25 | FDMT | 4D Molecular Therapeutics,… | AGRANT◆ | 217,000 | — | — | — | Open the original filing on SEC.gov |